The nation of Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (£272m) spanning five years over Washington's demand for sensitive information.
This rejection was revealed after a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the agreement was "skewed".
A government representative later clarified that the US was seeking biological samples for research and profit while refused to share the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged further talks to find a deal acceptable to both sides so the nation's critical HIV treatment initiative can be sustained.
Broader Context
This rejection follows a comparable case in neighbouring Kenya, where a high court suspended a related deal with the US after legal challenges were raised about the security of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the US government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to boost transparency and responsibility.
As per reports, 16 African countries have to date agreed to similar health pacts, representing over $18.3bn of fresh investment.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, without any equivalent guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," his statement read.
"Effectively, our nation would supply the basic resources for medical research without any certainty that the end products would be available to our population should a new pandemic arise."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending frameworks already established via the global health agency.
Mangwana cited its Pandemic Benefit-Sharing system designed to manage potential pandemics.
"This mechanism is designed to ensure that when a country contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.
"We are open to further dialogue with our US partners on how future collaboration could be arranged in a manner that respects the independence and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but urged that negotiations should continue given that a large portion of the country's Aids initiatives depended on international support.
"If specific concerns arise, such as those involving information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it added.
The halted deal emphasises the complex tensions between receiving vital international aid and safeguarding a country's data in an ever more data-driven world.